本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Janux Therapeutics, Inc.

23.01
-1.2900-5.31%
盤後23.010.00000.00%19:55 EDT
成交量:54.14萬
成交額:1,266.49萬
市值:13.83億
市盈率:-12.81
高:24.35
開:24.30
低:22.90
收:24.30
52周最高:71.71
52周最低:21.97
股本:6,009.39萬
流通股本:4,496.69萬
量比:0.66
換手率:1.20%
股息:- -
股息率:- -
每股收益(TTM):-1.7966
每股收益(LYR):-1.2836
淨資產收益率:-12.82%
總資產收益率:-10.51%
市淨率:1.40
市盈率(LYR):-17.93

資料載入中...

2024/11/08

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/11/06

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/06

重要事件披露

Form 8-K - Current report
2024/11/05

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/10/28

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/10/28

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/10/28

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/10/25

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/10/25

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/10/25

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/10/25

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/10/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/10/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/10/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities